搜尋結果
WeightWatchers Struggles to Adapt Amid GLP-1 Drug Boom
Bloomberg· 16 小時前Investors are waiting to see results from purchase of prescription service company
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
Reuters· 4 日前Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice ...
Inflammasome Therapeutics Announces First Patient Dosed in Geographic Atrophy (GA) Clinical Trial
Bastillepost· 6 日前Inflammasome Therapeutics ( https://www.inflam.com ), a private company developing a new class ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 2 日前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Amazon, CVS, Walgreens And Walmart Push To Let Pharmacists Prescribe Drugs
Forbes· 4 日前Many are pushing for more ways pharmacists can prescribe medications as drugs become ...
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is ...
Forbes· 2 日前Skepticism may be warranted when the Centers for Medicare and Medicaid Services’ Office of the ...
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
Forbes· 7 日前Barriers to access to these medicines disproportionately affect people in low- and ...
Cannabis Stocks Spike Following Reports Marijuana Will Be Reclassified As Less Dangerous Drug
Forbes· 5 日前Cannabis company stocks skyrocketed Tuesday following multiple reports marijuana will be ...
Real. Trial. Lawyers. Launch New Firm — SCHONBUCH HALLISSY LLP to Open Brentwood Office
Bastillepost· 3 日前The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less ...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 2 日前Have a confidential tip for our reporters? Novo Nordisk A/S shares fell as a US rival’s ...